Herceptin


Pictures of Herceptin

Videos of Herceptin

October 21, 2010

Access Pharmaceuticals Files Additional IP For Oral Drug Delivery Technology

Send by Proactive Investors USA & Cana

The patents cover oral formulations of injectables including cancer drugs Avastin and Herceptin, arthritis and psoriasis treatments Humira and Enbrel, [...]

October 21, 2010

Portrait Of A Survivor

Send by Leader

Paula Knapp is a breast cancer survivor after participating in a clinical trial for the drug herceptin. “I was told I had breast cancer, and as if that [...]

October 21, 2010

Salamat Dok: Breast Cancer

Send by ABS CBN News

She also had chemo- , radiation and herceptin therapies, typical treatments for the disease. “My oncologist suggested I do herceptin to fight cancer cells. [...]

October 21, 2010

NICE To Compare Tyverb, Herceptin In Breast Cancer

Send by FiercePharma

But as Dillon explains, NICE wants to compare Tyverb to Roche's Herceptin in patients with advanced, worsening breast cancer, which could lead to Tyverb [...]

October 21, 2010

Herceptin: A Wonder Drug, But Not A Miracle - The Globe And Mail


29 Mar 2010 The fast-tracked drug has saved hundreds of Canadian lives, but now the scientist who developed it is calling attention to its drawbacks. [...]

October 21, 2010

Trastuzumab (Herceptin) - Cancer Information - Macmillan Cancer ...


Information about the monoclonal antibody trastuzumab (Herceptin®) which is used to treat breast cancer. It describes how the drug works, how it is given [...]

October 21, 2010

Trastuzumab - Wikipedia, The Free Encyclopedia


Australian Government, Dept of Health and Ageing "Listing of Herceptin on Her-2: the making of Herceptin, a revolutionary treatment for breast cancer. [...]

October 21, 2010

BioPharma Investor: Roche And Immunogen Develop Highly Targeted ...

Send by BioPharma Investor; Troubled B

BOSTON (TheStreet) -- The "armed antibody" drug TDM-1 under development by Roche and ImmunoGen(IMGN) posted a higher response rate and lower toxicity than the blockbuster breast cancer drug Herceptin, according to results from the first [...]

October 21, 2010

Breast Cancer


Breast cancer (malignant breast neoplasm) is cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules that supply the ducts with milk. Cancers originating from ducts are known as ductal carcinomas; those originating from lobules are known as lobular car [...]

October 21, 2010

Hammer Stock Blog Blog Archive Immunogen Beyond The T-DM1 Delay

Send by Ohad Hammer

T-DM1's potential market remains unchanged, with a blockbuster potential based on the $4.8B in sales Herceptin had last year. Herceptin's sales will probably grow beyond $5B following the approval in HER2 positive gastric cancer. [...]

October 21, 2010

Trastuzumab In The Treatment Of Breast Cancer NEJM

Send by Gabriel N. Hortobagyi, MD

The results of three of these trials (the combined results of the National Surgical Adjuvant Breast and Bowel Project trial [B-31] and the North Central Cancer Treatment Group trial [N9831] and those of the Herceptin Adjuvant [HERA] [...]

October 21, 2010

Herceptin (trastuzumab) HER2+ Breast Cancer Treatment


Herceptin (trastuzumab) is part of a treatment plan for the adjuvant treatment of patients with HER2 overexpressing, node-positive HER2+ breast cancer. Who is Herceptin for? [...]

October 21, 2010

FDA Approves Roche Drug Herceptin For Advanced Stomach Cancer

Send by Wall Street Journal

VX) said the Food and Drug Administration has approved its blockbuster cancer drug Herceptin in combination with chemotherapy to treat advanced stomach [...]

October 21, 2010

Servicio De Noticas En Salud Al Da Piden Se Financie Herceptin ...

Send by Lic. Aleida Figueroa Silverio

El organismo supervisor de costos de salud de Gran Bretaña recomendó al Servicio Nacional de Salud (NHS) que financie el fármaco para el cáncer Herceptin, de Roche, a algunos pacientes con metástasis de cáncer de estómago. [...]

October 21, 2010

Herceptin HCP Print Ad Colombia 2009 At AdPharm Blog

Send by AdPharm

Herceptin – HCP print ad – Colombia – 2009 · without comments · Details and full-sized version available on AdPharm. Written by AdPharm. September 14th, 2010 at 1:05 pm. 6 views. Posted in AdPharm gallery,Advertising [...]

October 21, 2010

Glaxo Says Roche's Herceptin Infringes Patents

Send by EthiopianReview.com | DB

Roche, and its U.S. business Genentech, infringe the patent by “making and/or having made therapeutic antibody products, including without limitation Herceptin,” the complaint said. Glaxo is demanding damages to compensate for [...]

October 21, 2010

Celebrating A 5-year Milestone After Breast Cancer Diagnosis ...

Send by Julie Janovsky-Mason

The chemotherapy included a year's treatment with a relatively new drug, Trastuzumab, which Mayo had a hand in testing. Also known by the trade name, Herceptin, it “dramatically improves the outlook for women with this type of cancer,” [...]

October 21, 2010

NICE Seeks Appraisal Of Tyverb Plus Herceptin In Advanced Breast ...


The UK's National Institute for Health and Clinical Excellence (NICE) has requested permission to conduct an appraisal of GlaxoSmithKline's Tyverb in combination with Genentech's Herceptin in patients with advanced and metastatic breast [...]

October 21, 2010

Gene Profiling And Resistance To Herceptin

Send by James Hoag

"Herceptin has revolutionized the care of HER2-positive breast cancer for a number of patients, but unfortunately, not for some. This work demonstrates that digging deeper into the molecular subtypes of these tumors helps us understand [...]

October 21, 2010

Trastuzumab - Wikipedia, The Free Encyclopedia


Trastuzumab (INN; trade name Herceptin) is a monoclonal antibody that interferes with the HER2/neu receptor. The HER receptors are proteins that are embedded in the cell membrane and [...]

October 21, 2010

Glaxo Says Roche's Herceptin Infringes Patents

Send by news.yahoo.com

Drugmaker GlaxoSmithKline sued Swiss rival Roche Holding AG on Tuesday for infringing a patent when it produces its cancer drug Herceptin, according to court documents filed on Monday. [...]

October 21, 2010

Patent Battle Over Herceptin Silico Research

Send by silico

On September 21 2010 GlaxoSmithKline filed a suit against Roche Holding AG in Delaware for infringing a patent when it produces its cancer drug Herceptin. Glaxo said the patents were issued in 2008 and 2010 and cover antibody [...]

October 21, 2010

Trastuzumab (Herceptin) Approved For Certain Patients With Stomach ...


NHS regulator to approve stomach cancer drug. The National Institute for Health and Clinical Excellence changes its mind and plans to approve trastuzumab (Herceptin) for certain patients with metastatic gastric (stomach) cancer [...]

October 21, 2010

Glaxo Says Roche's Herceptin Infringes Patents (Reuters)


Reuters – Drugmaker GlaxoSmithKline sued Swiss rival Roche Holding AG on Tuesday for infringing a patent when it produces its cancer drug Herceptin, according to court documents filed on Monday. [...]

October 21, 2010

Taxol 2 And Herceptin 3

Send by Tina

I had my 2nd Taxol infusion yesterday. We were at the hospital 7 hours! It wouldn't have been quite that long, but my onc was about 45 min. late. We don't mind though. He is so good with his patients, and if he's running late its [...]


Submit article

Name:
E-Mail:
Source:
Article:
Please complete all the fields in order to take your article in consideration.